ClinConnect ClinConnect Logo
Search / Trial NCT07064915

Impact of a Medical-Financial Partnership Intervention on Parent Mental Health, Perinatal Outcomes, and Child Developmental Risk

Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Jul 7, 2025

Trial Information

Current as of July 21, 2025

Enrolling by invitation

Keywords

Medical Financial Partnership

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being an expectant parent (mother or father) who is either 1) receiving prenatal care or 2) their partner is receiving prenatal care at one of the study's prenatal care clinical sites during recruitment
  • Intending at the time of recruitment to have their child receive primary pediatric care at one of the of the study's pediatric primary care clinical sites after birth
  • Speaking English or Spanish as primary language
  • Exclusion Criteria:
  • Cognitive impairment or any other condition that would prevent participation in the intervention
  • Foster parents
  • Parent age under 18 at enrollment

About University Of California, Los Angeles

The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.

Locations

Harbor City, California, United States

Los Angeles, California, United States

Sylmar, California, United States

Torrance, California, United States

Patients applied

0 patients applied

Trial Officials

Adam Schickedanz, MD PhD

Principal Investigator

University of California, Los Angeles

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported